Gene Therapy Stocks Get Boost After Another Firm Is Bought

(Bloomberg) -- A trio of choice small-cap gene therapy companies were off to the races on Monday, adding to last week’s gains, after yet another peer got snapped up, this time by Biogen.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.